Aspirin for Primary Prevention of Cardiovascular Diseases: Current Concepts, Unanswered Questions and Future Directions

Hellenic J Cardiol. 2015 Nov-Dec;56(6):461-74.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Aspirin / pharmacology*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / prevention & control
  • Platelet Aggregation Inhibitors / pharmacology*
  • Primary Prevention / methods*
  • Risk Factors

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin